Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AVTX

Avalo Therapeutics Inc

May 06 • 04:00PM ET

21.81

+5.55 34.13 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: VRTX REGN AMGN BIIB GILD INCY ILMN ALNY NBIX ONC

| Held by: VTI VXF ITOT IWC DFAS MEDI TMED DFMC DXUV

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.10	Insider Own	10.04%	Shs Outstand	26.71M	Perf Week	65.23%
Market Cap	582.64M	Forward P/E	-	EPS next Y	-4.03	Insider Trans	-2.70%	Shs Float	24.03M	Perf Month	37.00%
Enterprise Value	486.70M	PEG	-	EPS next Q	-1.03	Inst Own	76.67%	Short Float	21.80%	Perf Quarter	51.77%
Income	-78.26M	P/S	9710.67	EPS this Y	39.48%	Inst Trans	44.67%	Short Ratio	4.61	Perf Half Y	30.83%
Sales	0.06M	P/B	4.86	EPS next Y	-14.08%	ROA	-58.31%	Short Interest	5.24M	Perf YTD	20.10%
Book/sh	4.49	P/C	5.92	EPS next 5Y	14.19%	ROE	-72.43%	52W High	20.72 5.26%	Perf Year	356.28%
Cash/sh	3.68	P/FCF	-	EPS past 3/5Y	82.35% 70.20%	ROIC	-91.98%	52W Low	3.39 543.36%	Perf 3Y	-96.50%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-85.16% -61.19%	Gross Margin	-483.05%	Volatility	14.55% 10.05%	Perf 5Y	-99.73%
Dividend TTM	-	EV/Sales	8111.67	EPS Y/Y TTM	95.62%	Oper. Margin	-123601.69%	ATR (14)	1.71	Perf 10Y	-99.80%
Dividend Ex-Date	-	Quick Ratio	8.14	Sales Y/Y TTM	-86.62%	Profit Margin	-132642.37%	RSI (14)	76.37	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.14	EPS Q/Q	78.04%	SMA20	51.00%	Beta	0.85	Target Price	46.90
Payout	-	Debt/Eq	0.03	Sales Q/Q	-69.27%	SMA50	42.15%	Rel Volume	29.06	Prev Close	16.26
Employees	33	LT Debt/Eq	0.02	Earnings	Mar 23 BMO	SMA200	51.35%	Avg Volume	1.14M	Price	21.81
IPO	Nov 13, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	47.48% -	Trades		Volume	22,460,396	Change	34.13%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)